$359 Million is the total value of Samsara BioCapital, LLC's 36 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FMTX | Sell | Forma Therapeutics Holdings, Inc. | $74,369,000 | +1.3% | 1,492,163 | -5.5% | 20.74% | -12.1% |
| NKTX | New | Nkarta, Inc. | $61,163,000 | – | 2,034,703 | +100.0% | 17.06% | – |
| ISEE | Iveric Bio, Inc. | $19,009,000 | +10.6% | 3,370,478 | 0.0% | 5.30% | -4.1% | |
| SWTX | Sell | Springworks Therapeutics Inc | $18,973,000 | -18.9% | 398,017 | -28.6% | 5.29% | -29.7% |
| CVAC | New | CureVac N.V. | $17,241,000 | – | 370,385 | +100.0% | 4.81% | – |
| STRO | Sutro BioPharma Inc | $16,840,000 | +29.5% | 1,675,579 | 0.0% | 4.70% | +12.3% | |
| ICPT | Intercept Pharmaceuticals Inc | $16,737,000 | -13.5% | 403,688 | 0.0% | 4.67% | -25.0% | |
| ALLK | Sell | Allakos Inc | $15,666,000 | -10.6% | 192,334 | -21.1% | 4.37% | -22.5% |
| UMRX | New | Unum Therapeutics, Inc. | $13,295,000 | – | 5,681,818 | +100.0% | 3.71% | – |
| SYRS | Sell | Syros Pharmaceuticals Inc | $11,608,000 | -26.8% | 1,407,949 | -10.4% | 3.24% | -36.6% |
| ODT | Buy | Odonate Therapeutics Inc | $10,951,000 | -47.9% | 815,421 | +64.2% | 3.06% | -54.8% |
| BCEL | Buy | Atreca Inc | $8,627,000 | -20.6% | 617,560 | +21.0% | 2.41% | -31.1% |
| VRNA | Buy | Verona Pharma PLC.spons ads | $6,933,000 | +3315.3% | 1,111,112 | +2456.9% | 1.93% | +2875.4% |
| AGLE | Sell | Aeglea BioTherapeutics, Inc. | $6,266,000 | -30.0% | 883,720 | -8.7% | 1.75% | -39.3% |
| EQ | New | Equillium, Inc. | $6,199,000 | – | 1,074,285 | +100.0% | 1.73% | – |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $5,534,000 | +31.0% | 2,153,265 | -17.4% | 1.54% | +13.6% |
| BCTG | New | BCTG Acquisition Corp | $5,180,000 | – | 500,000 | +100.0% | 1.44% | – |
| RYTM | Sell | Rhythm Pharmaceuticals Inc | $5,089,000 | -17.4% | 234,846 | -15.0% | 1.42% | -28.4% |
| PANAU | New | Panacea Acquisition Corp.unit | $4,800,000 | – | 400,000 | +100.0% | 1.34% | – |
| ALPN | New | Alpine Immune Sciences Inc | $4,344,000 | – | 494,190 | +100.0% | 1.21% | – |
| KALA | Buy | Kala Pharmaceuticals Inc | $3,384,000 | -5.1% | 451,162 | +33.0% | 0.94% | -17.7% |
| ALBO | New | Albireo Pharma, Inc. | $3,337,000 | – | 100,000 | +100.0% | 0.93% | – |
| GERN | Sell | Genron Corporation | $2,664,000 | -68.6% | 1,531,088 | -60.6% | 0.74% | -72.8% |
| ALVR | New | Allovir, Inc | $2,504,000 | – | 91,057 | +100.0% | 0.70% | – |
| NVAX | New | Novavax, Inc. | $2,347,000 | – | 21,660 | +100.0% | 0.66% | – |
| FULC | Fulcrum Therapeutics, Inc. | $2,332,000 | -56.6% | 294,118 | 0.0% | 0.65% | -62.4% | |
| RCKT | Sell | Rocket Pharmaceuticals Inc | $2,278,000 | -21.2% | 99,643 | -27.9% | 0.64% | -31.7% |
| AIMT | Sell | Aimmune Therapeutics, Inc. | $2,003,000 | -48.5% | 58,142 | -75.0% | 0.56% | -55.3% |
| Catabasis Pharmaceuticals Inc | $1,857,000 | -3.7% | 300,000 | 0.0% | 0.52% | -16.6% | ||
| SPRO | New | Spero Therapeutics, Inc. | $1,786,000 | – | 160,000 | +100.0% | 0.50% | – |
| UROV | Urovant Sciences Ltd | $1,471,000 | -5.1% | 157,480 | 0.0% | 0.41% | -17.8% | |
| HOOK | Sell | Hookipa Pharma Inc | $1,104,000 | -76.3% | 116,602 | -70.9% | 0.31% | -79.4% |
| KALV | Sell | KalVista Pharmaceuticals Inc | $1,059,000 | -48.0% | 84,087 | -50.0% | 0.30% | -55.0% |
| BNTX | New | BioNTech SEspons ads | $879,000 | – | 12,700 | +100.0% | 0.24% | – |
| NGM | Sell | NGM Biopharmaceuticals, Inc. | $580,000 | -39.5% | 36,451 | -25.0% | 0.16% | -47.6% |
| AMRN | Sell | Amarin Corp PLCspons adr new | $105,000 | -69.7% | 25,000 | -50.0% | 0.03% | -73.9% |
| AKRO | Exit | Akero Therapeutics, Inc. | $0 | – | -22,234 | -100.0% | -0.18% | – |
| ASMB | Exit | Assembly Biosciences Inc. | $0 | – | -29,740 | -100.0% | -0.22% | – |
| SLNO | Exit | Soleno Therapeutics, Inc. | $0 | – | -750,000 | -100.0% | -0.54% | – |
| BLU | Exit | Bellus Health Inc | $0 | – | -333,631 | -100.0% | -1.11% | – |
| PIRS | Exit | Pieris Pharmaceuticals Inc | $0 | – | -1,620,249 | -100.0% | -1.67% | – |
| PTLA | Exit | Portola Pharmaceuticals Inc | $0 | – | -318,429 | -100.0% | -1.70% | – |
| ARAV | Exit | Aravive Inc | $0 | – | -576,066 | -100.0% | -2.16% | – |
| PRNB | Exit | Principia Biopharma Inc | $0 | – | -342,946 | -100.0% | -6.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.